ARCHIVES

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Older Patients Tolerate Chemo, Decline Due To Severe Toxicity

February 28, 2003

Interferon “Hysteria” Prompts ASCO To Warn Against Expecting Immediate Benefits

June 20, 1980

In Brief: Senate Committee Finishes Work On Renewal Bill, Both Houses (So Far) Leave NCI Authorities Intact

May 21, 1982

Enzastaurin Shows Activity In Recurrent High-Grade Glioma

June 24, 2005

Phase II ThermoDox Trial Demonstrates Positive Response

August 29, 2014

NCI Contracts: Advisors OK Renewal Of chemoprevention Contracts By DCPC

September 6, 1996